← Human Trials & Peer-Reviewed Studies
[The influence of combined supplementation of glutamine and recombinant human growth hormone on the protein metabolism in severely burned patients].
Plain-language guide to PMID 15447822 (2004): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 3 patients.
Key Facts
- PMID
- 15447822
- Journal
- Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
- Year
- 2004
- Study type
- Randomized Controlled Trial
- Authors
- Lu CJ et al. (6 authors)
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
To investigate the influence of combined supplementation of glutamine (Gln) and recombinant human growth hormone (rhGH) on the protein metabolism in severely burned patients.
Who Took Part
The study group was 3 patients.
PubMed indexes the participants as young adults, adults, middle-aged adults and older adults, both men and women.
Sixty severely burned patients were enrolled in the study and were randomly divided into control (C, n = 20) and Gln with rhGH (Gln + rhGH, n = 20) groups.
The plasma Gln concentration in the 3 groups of patients was determined on the 1st, 7th and 14th PBD and the plasma albumin level was determined on 14th and 21st PBD.
How the Study Was Run
The researchers set it up as a randomized and placebo-controlled study.
The patients were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.
The wound healing rate of the patients within 30 PBSs and the total hospital stay days were recorded.
What Was Measured
The subject headings attached to it are Burns, Glutamine, Human Growth Hormone, Recombinant Proteins and Wound Healing.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 3 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2004 (Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns), a journal based in China.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.